Related Experiment Video
Updated: May 3, 2026

Protocols for Implementing an Escherichia coli Based TX-TL Cell-Free Expression System for Synthetic Biology
Published on: September 16, 2013
Cellular Coupling Fermentation Utilizing Engineered Escherichia coli and Yeast for Efficient Biosynthesis of
Huanle Gao1,2, Cheng Han1,2, Zimeng Zhang1,2
1Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, China.
Abstract:
Sialyllacto-N-tetraose a (LSTa) is a representative member of sialylated human milk oligosaccharides (HMOs) that exhibits distinctive physiological properties, including antiviral defense and modulation of intestinal immunity. Efficient synthesis of LSTa remains a central challenge in the research on complex sialylated HMOs. To address the challenges of large-scale production, this study screened a highly efficient α-2,3-sialyltransferase to establish a glycosyltransferase module in Escherichia coli, and it was functionally coupled with Saccharomyces cerevisiae for endogenous cytidine-5'-triphosphate (CTP) cofactor regeneration. LSTa was successfully synthesized via a modular biosynthesis strategy, utilizing N-acetylneuraminic acid (Neu5Ac) and lacto-N-tetraose (LNT) as substrates. Then through systematic optimization of induction parameters and catalytic reaction conditions, LSTa productivity and substrate conversion efficiency were substantially enhanced. Ultimately, a whole-cell catalytic process was implemented in a 5 L bioreactor, achieving a maximum titer of 38.03 g/L for LSTa, demonstrating the scalability and potential for the biosynthesis of complicated sialylated HMOs.
More Related Videos
05:44Assembly and Quantification of Co-Cultures Combining Heterotrophic Yeast with Phototrophic Sugar-Secreting Cyanobacteria
Published on: December 27, 2024
14:53Techniques for the Evolution of Robust Pentose-fermenting Yeast for Bioconversion of Lignocellulose to Ethanol
Published on: October 24, 2016
Related Concept Videos
Bioreactor Controls-III
Microbial Fermentation
Production of Pharmaceuticals
Upstream Processing